The Sustained Release of Biologics, Large, & Small Molecules with Novel Photo Crosslinked Biodegradable Technologies
- Transforming Anti-VEGF Delivery: How Re-Vana’s sustained-release technology could reduce injection frequency for patients with retinal diseases
- Innovation at the Interface of Science & Patient Care: The science behind ReVana’s biodegradable implants and why it matters for the future of ophthalmology, including novel sustained release therapeuticsÂ
- Opportunities for Collaboration & Impact: Where Re-Vana is today and the potential paths forward, clinical development, partnerships, and commercial strategy